We set out to characterize the expression of CD43 by FC in B-cell lymphoproliferative disorders and to determine its possible role in the differential diagnosis of these malignancies.

A diagnosis of typical chronic lymphocytic leukemia (CLL) requires the presence of ≥5000 clonal B-lymphocytes/μL, the coexistence of CD19, CD20, CD5, and CD23, the restriction of light …

Flow cytometric analysis of bone marrow demonstrates 62% lymphocytes with CD19+, CD5+, CD10-, CD43+, CD23+, CD200+, CD38-, CD20 (dim)+, sIgL-kappa (dim)+ immunophenotype …

May 25, 2018 · CD43 expression was 95.7% in atypical CLL cases. In the MCL cases, its expression rate was 39.4%. Conclusion: CD43 and CD200 were found to be more valuable …

Nov 30, 2023 · CD43 and CD200 are useful markers in differentiating CLL from other mature B-cell neoplasms with higher MFI expression of both markers found in CLL. Mature B-cell …

In population of peripheral B cells CD43 occurs only on activated B cells and CD5 positive B cells. These last cells create neoplasm population in patients with B-cell chronic lymphocytic …

CD43 and CD200 were found to be more valuable markers than CD22, CD79b, and FMC7. CD43 and CD200 could also be considered as definitive markers in atypical CLL patients, for whom …

Results: CD43 was positively expressed in all CLL cases, while intracellular expression of CD180 was found to be positive in 89.5% of CLL cases. Data analysis demonstrated that the …

Jun 1, 2021 · CD43 is a surface molecule expressed on T cells but positive in CLL. 19 CD43 positivity was a marker with a sensitivity of 100% for CLL diagnosis. 20 CD 43 is …

Jan 10, 2017 · We set out to characterize the expression of CD43 by FC in B-cell lymphoproliferative disorders and to determine its possible role in the differential diagnosis of …